159 related articles for article (PubMed ID: 34509390)
1. Synthesis and characterization of amoxicillin-loaded polymeric nanocapsules as a drug delivery system targeting Helicobacter pylori.
Abdelghany A; El-Desouky MA; Shemis M
Arab J Gastroenterol; 2021 Dec; 22(4):278-284. PubMed ID: 34509390
[TBL] [Abstract][Full Text] [Related]
2. Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.
Thombre NA; Gide PS
Drug Deliv; 2016; 23(2):405-19. PubMed ID: 24870198
[TBL] [Abstract][Full Text] [Related]
3. Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres.
Patel JK; Patel MM
Curr Drug Deliv; 2007 Jan; 4(1):41-50. PubMed ID: 17269916
[TBL] [Abstract][Full Text] [Related]
4. Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of
Yang SJ; Huang CH; Yang JC; Wang CH; Shieh MJ
ACS Appl Mater Interfaces; 2020 Dec; 12(49):54316-54327. PubMed ID: 33236884
[No Abstract] [Full Text] [Related]
5. Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy.
Patel JK; Chavda JR
J Microencapsul; 2009 Jun; 26(4):365-76. PubMed ID: 18720199
[TBL] [Abstract][Full Text] [Related]
6. Polyelectrolyte coated multilayered liposomes (nanocapsules) for the treatment of Helicobacter pylori infection.
Jain P; Jain S; Prasad KN; Jain SK; Vyas SP
Mol Pharm; 2009; 6(2):593-603. PubMed ID: 19718807
[TBL] [Abstract][Full Text] [Related]
7. Dual drug delivery system for targeting H. pylori in the stomach: preparation and in vitro characterization of amoxicillin-loaded Carbopol® nanospheres.
Harsha S
Int J Nanomedicine; 2012; 7():4787-96. PubMed ID: 22969298
[TBL] [Abstract][Full Text] [Related]
8. Experimental design and optimization of a novel dual-release drug delivery system with therapeutic potential against infection with Helicobacter pylori.
Arrua EC; Sanchez SV; Trincado V; Hidalgo A; Quest AFG; Morales JO
Colloids Surf B Biointerfaces; 2022 May; 213():112403. PubMed ID: 35219219
[TBL] [Abstract][Full Text] [Related]
9. Floating mucoadhesive alginate beads of amoxicillin trihydrate: A facile approach for H. pylori eradication.
Dey SK; De PK; De A; Ojha S; De R; Mukhopadhyay AK; Samanta A
Int J Biol Macromol; 2016 Aug; 89():622-31. PubMed ID: 27177460
[TBL] [Abstract][Full Text] [Related]
10. New Silver(I) Coordination Compound Loaded into Polymeric Nanoparticles as a Strategy to Improve
Almeida Furquim de Camargo B; Soares Silva DE; Noronha da Silva A; Campos DL; Machado Ribeiro TR; Mieli MJ; Borges Teixeira Zanatta M; Bento da Silva P; Pavan FR; Gallina Moreira C; Resende FA; Menegário AA; Chorilli M; Vieira de Godoy Netto A; Bauab TM
Mol Pharm; 2020 Jul; 17(7):2287-2298. PubMed ID: 32515970
[No Abstract] [Full Text] [Related]
11. Synthesis and in vitro studies of cross-linked hydrogel nanoparticles containing amoxicillin.
Moogooee M; Ramezanzadeh H; Jasoori S; Omidi Y; Davaran S
J Pharm Sci; 2011 Mar; 100(3):1057-66. PubMed ID: 21280053
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Helicobacter pylori infection in patients with large gastric folds: evaluation and follow-up with endoscopic ultrasound before and after antimicrobial therapy.
Avunduk C; Navab F; Hampf F; Coughlin B
Am J Gastroenterol; 1995 Nov; 90(11):1969-73. PubMed ID: 7485002
[TBL] [Abstract][Full Text] [Related]
13. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
14. Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori.
Wang J; Tauchi Y; Deguchi Y; Morimoto K; Tabata Y; Ikada Y
Drug Deliv; 2000; 7(4):237-43. PubMed ID: 11195431
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori.
Rajinikanth PS; Balasubramaniam J; Mishra B
Int J Pharm; 2007 Apr; 335(1-2):114-122. PubMed ID: 17141986
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter suis infection is associated with nodular gastritis-like appearance of gastric mucosa-associated lymphoid tissue lymphoma.
Takigawa H; Masaki S; Naito T; Yuge R; Urabe Y; Tanaka S; Sentani K; Matsuo T; Matsuo K; Chayama K; Kitadai Y
Cancer Med; 2019 Aug; 8(9):4370-4379. PubMed ID: 31210418
[TBL] [Abstract][Full Text] [Related]
17. Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model.
Umamaheshwari RB; Ramteke S; Jain NK
AAPS PharmSciTech; 2004 Apr; 5(2):e32. PubMed ID: 15760090
[TBL] [Abstract][Full Text] [Related]
18. Novel and Effective Therapeutic Regimens for
Hu Y; Zhu Y; Lu NH
Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
[No Abstract] [Full Text] [Related]
19. Gastroprotective effects of Hwanglyeonhaedok-tang against Helicobacter pylori-induced gastric cell injury.
Park HS; Wijerathne CUB; Jeong HY; Seo CS; Ha H; Kwun HJ
J Ethnopharmacol; 2018 Apr; 216():239-250. PubMed ID: 29410309
[TBL] [Abstract][Full Text] [Related]
20. Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori.
Luo M; Jia YY; Jing ZW; Li C; Zhou SY; Mei QB; Zhang BL
Colloids Surf B Biointerfaces; 2018 Apr; 164():11-19. PubMed ID: 29367052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
